Baron Financial Group, LLC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 138 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baron Financial Group, LLC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2022$1,574,000
-41.6%
1000.0%0.00%
-50.0%
Q1 2022$2,696,000
-27.2%
1000.0%0.00%0.0%
Q4 2021$3,701,000
-22.5%
1000.0%0.00%
-33.3%
Q3 2021$4,778,000
+41.2%
1000.0%0.00%
+50.0%
Q2 2021$3,384,000
-18.1%
1000.0%0.00%
-33.3%
Q1 2021$4,130,000
-4.8%
1000.0%0.00%0.0%
Q4 2020$4,338,000
+1.1%
1000.0%0.00%
-25.0%
Q3 2020$4,290,0001000.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q4 2020
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders